Skip to main content
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2016 Sep 26;26(18):2486–2491. doi: 10.1016/j.cub.2016.07.013

Inhibitory Interplay between Orexin Neurons and Eating

J Antonio González 1,6, Lise T Jensen 2,6, Panagiota Iordanidou 1, Molly Strom 3, Lars Fugger 2,4,, Denis Burdakov 1,5,7,∗∗
PMCID: PMC5049542  PMID: 27546579

Summary

In humans and rodents, loss of brain orexin/hypocretin (OH) neurons causes pathological sleepiness [1, 2, 3, 4], whereas OH hyperactivity is associated with stress and anxiety [5, 6, 7, 8, 9, 10]. OH cell control is thus of considerable interest. OH cells are activated by fasting [11, 12] and proposed to stimulate eating [13]. However, OH cells are also activated by diverse feeding-unrelated stressors [14, 15, 16, 17] and stimulate locomotion and “fight-or-flight” responses [18, 19, 20]. Such OH-mediated behaviors presumably preclude concurrent eating, and loss of OH cells produces obesity, suggesting that OH cells facilitate net energy expenditure rather than energy intake [2, 21, 22, 23]. The relationship between OH cells and eating, therefore, remains unclear. Here we investigated this issue at the level of natural physiological activity of OH cells. First, we monitored eating-associated dynamics of OH cells using fiber photometry in free-feeding mice. OH cell activity decreased within milliseconds after eating onset, and remained in a down state during eating. This OH inactivation occurred with foods of diverse tastes and textures, as well as with calorie-free “food,” in both fed and fasted mice, suggesting that it is driven by the act of eating itself. Second, we probed the implications of natural OH cell signals for eating and weight in a new conditional OH cell-knockout model. Complete OH cell inactivation in adult brain induced a hitherto unrecognized overeating phenotype and caused overweight that was preventable by mild dieting. These results support an inhibitory interplay between OH signals and eating, and demonstrate that OH cell activity is rapidly controllable, across nutritional states, by voluntary action.

Highlights

  • Brain orexin cell activity is rapidly inactivated upon the act of eating

  • This occurs with different foods, including calorie-free and liquid food

  • Complete orexin cell inactivation in adult brain can promote overeating

  • Overweight resulting from orexin cell loss is reversible by mild dieting


Brain orexin cells control arousal, but pathological deregulation of their activity can produce sleepiness, obesity, and anxiety. González et al. show that the voluntary act of eating can rapidly downregulate orexin cell activity irrespective of taste or calories, whereas obesity resulting from orexin underactivity can be reversed by a mild diet.

Results and Discussion

Natural Population Dynamics of OH Cells during Voluntary Eating

Orexin/hypocretin (OH) cells are activated by fasting and low glucose levels, and have been hypothesized to drive eating until ingested glucose slowly (within minutes) inactivates them (Figure 1A) [19, 24]. We measured OH cell population activity in freely behaving mice using fiber photometry [17] of the GCaMP6s activity indicator targeted to OH cells while monitoring eating using video tracking or touch sensors (Figure 1B; Figures S1–S3). In freely behaving mice, we observed activity fluctuations in OH-GCaMP6s, but not in OH-eGFP, cells (Figure 1C). The magnitude of these fluctuations (∼10%–40% ΔF/F) was similar to network dynamics recorded with similar methods in other brain regions [25, 26]. Our experimental quantification of photometry performance suggested that >95% of the fluorescence signal would come from ∼0.5 mm from the fiber tip (Figures S2A and S2B), which is well suited to OH cluster dimensions in the mouse hypothalamus. We confirmed that the GCaMP6s signal reflects physiological OH cell modulation by reproducing the previously described in vivo activation of OH cells by sounds [14] and in vitro inhibition of OH cells by glucose [24] (Figures S1C and S1D). The OH-GCaMP6s signal was directly proportional to the OH cell firing rate (Figure S3).

Figure 1.

Figure 1

Impact of Eating on Natural OH Cell Dynamics In Vivo

(A) A hypothesis for temporal modulation of OH cells during eating.

(B) Left: targeting scheme of GCaMP6s to OH cells for obtaining the data shown in this figure (data using alternative targeting of OH cells are shown in Figures S2C–S2F). Right: localization of injection site and path of the optical fiber. 3V, third ventricle; L, D, M, V, lateral, dorsal, medial, ventral; VMH, ventromedial hypothalamus; Arc, arcuate nucleus. Representative image of n = 5 brains.

(C) Left: recording scheme. Right: fluorescence trace during cage exploration for mice expressing GCaMP6s or eGFP in OH neurons. Typical examples of n = 5 and n = 3 mice, respectively.

(D) Fluorescence trace during introduction of food into the cage and its subsequent consumption (orange-shaded area). Food was a drop of strawberry milkshake. Typical example of n = 5 mice.

(E) Left: fluorescence trace during repeated bouts of food contact (orange-shaded areas; food is strawberry milkshake). Typical example of n = 5 mice. Right: quantification of fluorescence change during the first 2 s of consecutive food-contact bouts (means ± SEM, n = 3 mice).

(F) Fluorescence change during food licking detected with a touch sensor (food is strawberry milkshake). Typical example of n = 5 mice across eight foods shown in (H), right.

(G) Top: probability density of OH cell activity. Bottom: distribution of the bootstrap differences of the same data. Typical example of n = 3 mice.

(H) Left: peri-event plots aligned to the onset of licking bouts (dashed line). The heatmap shows individual bouts (two per mouse), and the trace below the heatmap shows the mean of trial averages from each mouse (red line; gray lines represent SEM); n = 5 mice. Right: quantification of the experiment shown on the left, for different foods. Each column shows fluorescence change during the first 4 s of a licking bout (mean signals during 3.5 to 4 s minus signal during −0.5 to 0 s, times relative to the first lick). Data are means ± SEM of n = 4 mice in each group. Left column is control (OH-eGFP mice); other columns are OH-GCaMP6s mice; for food abbreviations, see the Supplemental Experimental Procedures; fast, overnight fasted before the experiment; fed, ad libitum feeding before the experiment. All changes in OH-GCaMP6s mice were significant (p < 0.05 in one-sample t tests of response to each food, DF = 3, t > 3.4).

See also Figures S1–S3 and Movie S1.

We found that food contact depressed OH cell activity extremely rapidly (<1 s of food contact) (Figures 1D–1H). OH cells returned to an up state within seconds after food contact was stopped (Figures 1D–1F; Figure S2E), suggesting that the rapid OH cell modulation is not caused by slowly varying nutritional signals. This effect was seen in both fasted and fed OH-GCaMP6s mice, but not in the OH-eGFP controls (Figure 1H). For liquid foods, the fall in OH cell activity was apparent within just a few licks (Figure 1F; Figures S2E and S2F). The eating-associated OH cell depression was similar for foods of differing consistency (e.g., chow versus yogurt) and different appetitive value (e.g., chow versus peanut butter) (Figure 1H). To confirm whether caloric content had a role, we tested a zero-calorie “food” (sucralose solution), and still observed robust OH cell inactivation during licking (Figure 1H). Overall, these data show that OH cells are rapidly inactivated by the act of eating, irrespective of food properties or body energy state.

Natural Impact of OH Neurons on Eating

The above correlative data have two possible causal interpretations: (1) OH cells oppose eating, and are disabled to enable eating, or (2) OH cells drive eating, and so eating stops shortly after OH cells are silenced. To distinguish between these possibilities, we investigated causality between natural OH activity and eating by inactivating OH cells in adult mice through a toxin receptor-mediated cell-knockout strategy [27, 28].

We generated new transgenic mice in which the expression of the human diphtheria toxin receptor (DTR) is driven by the OH promoter (see the Supplemental Experimental Procedures). In OH-DTR mice, but not in control WT mice, the injection of diphtheria toxin ablated all OH cells, but not the neighboring melanin-concentrating hormone-containing cells, within a couple of days (Figures 2A–2D). This complete inactivation of OH cells, which is not as readily achievable through alternative silencing methods such as opto- and chemo-genetics, may be critical for elucidation of their full impact, because key deficiency phenotypes are not apparent upon partial inactivation [13].

Figure 2.

Figure 2

Impact of Natural OH Cell Activity on Spontaneous Feeding Rhythm

(A) Strategy for destroying OH neurons in adult mice.

(B) Immunostaining for OH (green) and melanin-concentrating hormone-containing (MCH) (red) neurons in DTR (top) and DTR+ (bottom) littermates 10 days after DT injection. The DT injection led to the loss of OH neurons in all brains tested (n = 8). Scale bars represent 500 μm (left) and 100 μm (right). Dashed boxes in the left-hand panels indicate the areas shown in corresponding right-hand panels.

(C) Time course of OH cell loss after DT injection in DTR+ and their DTR littermates (n = 5 mice in each group).

(D) Quantification of OH cell number >21 days after DT injection in DTR and DTR+ littermates. Unpaired t test, t(13.3) = 16.41, p = 3.2e-10, n = 8 mice in each group.

(E) Body weight time series of DTR and DTR+ littermates after DT injection. ANCOVA, F(1, 12) = 12.07, p = 0.005, n = 7 mice in each group.

(F) Daily rhythm of eating in DTR and DTR+ mice after DT injection, across days. n = 7 mice in each group.

(G) Mean daily rhythm of eating (average of 14 days; gray box is lights off) in DT-injected DTR and DTR+ mice. Repeated-measures ANOVA, interaction: F(7, 84) = 2.38, p = 0.029. Significant differences were found only at the time of day indicated (∗∗∗p < 0.001, Holm correction for multiple comparisons). n = 7 mice in each group.

(H) Total food consumed after DT injection, relative to the time of day. Repeated-measures ANOVA, interaction: F(7, 84) = 3.07, p = 0.006. Pairwise comparisons revealed statistical differences at the time of day indicated (∗∗∗p < 0.001, Holm correction for multiple comparisons). n = 7 animals in each group.

See also Figure S4.

DT injection led to greater weight gain in DTR+ mice than in their DTR littermates (Figure 2E), confirming that OH cells oppose overweight. Next, we probed food intake patterns at an hourly temporal resolution, using a food hopper specifically designed to re-capture any food spillage and a food-weighing system whose errors were sufficiently low to report changes greater than 0.01 g (Figures S4A–S4D). In DTR mice injected with DT (control mice) this revealed a robust daily eating rhythm, where food intake was largely restricted to the lights-off phase (“night”) but had a pronounced “dip” late at night (Figures 2F and 2G). However, in DTR+ mice injected with DT, this dip in eating was significantly reduced, causing them to consume significantly more food during the late night (Figures 2F–2H; note that the magnitude of this overeating is well above the sensitivity limit of the food-weight detector; Figures S4A–S4D). Interestingly, this overeating did not cause compensatory undereating at other times of day (Figures 2F–2H). Glucose tolerance in OH cell-deficient mice was normal (Figure S4E), as previously observed for OH-deficient humans [29], suggesting that OH cell loss does not prevent glucose uptake from blood into tissues. Overall, these data show that the natural OH cell activity prevents overeating and suppresses weight gain.

Temporal Dissociation of Fasting-Dependent and OH-Dependent Eating

The above findings demonstrate that the natural activity of OH cells opposes eating, and therefore challenge current models postulating that OH cells stimulate eating. However, because OH cells are activated by fasting, it is still possible that they become critical for compensatory eating after fasting [11]. To examine this possibility, we measured rebound overeating after fasting in OH mice (i.e., DTR+ mice injected with DT), but surprisingly found it similar to their OH+ littermates (DTR mice injected with DT) (Figures 3A and 3B). Furthermore, although both the OH and OH+ mice overate for several days after fasting, on each of these days they ate more only in the early-night phase (Figures 3C and 3D), i.e., a different phase from that when food intake was naturally regulated by OH cells (Figure 2G). This temporal dissociation reveals that, at least under the conditions studied here, nutrient shortage and OH cells regulate distinct daily phases of food intake. These data suggest that OH cells are not required for compensatory overeating after fasting, at least when food is readily available.

Figure 3.

Figure 3

Impact of Natural OH Cell Activity on Rebound Eating after Fasting

(A) Eating responses to a 1-day fast in control mice (OH+, DTR mice injected with DT) and their OH cell-deficient littermates (OH, DTR+ mice injected with DT). n = 6 mice in each group.

(B) Daily eating rhythms before and after a 1-day fast in OH+ and OH littermates. n = 6 mice in each group.

(C) Daily eating rhythms 3 days before and after food restriction. Repeated-measures ANOVA, interaction: F(7, 35) = 3.36, p = 0.008 (left) and F(7, 35) = 3.53, p = 0.006 (right). Follow-up tests showed significant differences only at times marked with asterisks (∗∗p < 0.01, ∗∗∗p < 0.001, Holm correction for multiple comparisons). n = 6 mice in each group.

(D) Total food consumed 3 days before (fed) and 3 days after (fast) food restriction in OH+ and OH mice (n = 6 in each group) during early night (ZT12–14) compared to that consumed during late night (ZT18–20). Paired t tests.

Normalizing Eating Prevents Weight Gain in OH Cell-Deficient Mice

Identifying an effective strategy for body weight control in OH-deficient individuals is of clinical interest [21, 30]. In our experiments, the overeating in the OH mice (∼10 g of food over 50 days or ∼2% daily) could be theoretically sufficient to account for the overweight in these mice based on the following reasoning. The OH mice gain ∼10% weight (relative to OH+ controls) over about 45 days, i.e., ∼0.2% daily excess weight gain (Figure 2E). Our fasting experiment shows that, in 1 day, a 100% change in food intake can cause a 10% change in weight (Figure 3A). If this 10:1 relation holds in general, then the ∼2% daily eating increase would be sufficient to account for the 0.2% daily excess weight gain.

Therefore, we investigated whether the excess weight gain in the OH mice can be controlled by mild dietary restriction. To achieve this, we employed the pair-feeding paradigm [31], where the food available to each OH mouse was matched daily to that eaten by its OH+ littermate control (Figure 4A). This effectively fixes food intake, but in a mild physiological manner without abnormal periods of fasting [31].

Figure 4.

Figure 4

Prevention of Weight Gain Caused by OH Cell Loss by Dieting

(A) Strategy for pair-feeding experiment (OH+, DTR mice injected with DT; OH, their DTR+ littermates injected with DT).

(B) Weight gain of OH and OH+ littermates during weeks 2 and 3 after DT injection, and during free feeding (unpaired t test, t(11.93) = −4.327, p = 0.0009, n = 7 mice in each group) and pair feeding (unpaired t test, t(5.41) = −0.598, p = 0.574, n = 4 animals in each group).

Pair feeding the OH mice prevented them from becoming heavier than their OH+ siblings (Figure 4B). In contrast, in control experiments performed during the same time, free-feeding OH mice became significantly heavier than their OH+ siblings (Figure 4B). Note that this does not exclude that factors other than eating may mediate weight gain of OH mice, for example, alterations in sleep/wake rhythms and energy expenditure [2, 31, 32]. However, our results do suggest that, in the absence of overeating, such factors are insufficient to cause the excessive weight gain.

Conclusions

Our findings reveal population activity dynamics of OH cells during eating, and suggest that eating is less likely to occur when OH cells are naturally active. OH cells stimulate “non-eating” behaviors such as locomotion [18]. Although these behaviors expend energy, it is difficult to eat while performing them. Thus, a possible evolutionary rationale for our findings is that suppression of OH-dependent non-eating behaviors—by silencing OH cells upon food contact—would facilitate eating (e.g., by making the mouse less likely to move away from the food). It is tempting to speculate that increased eating after experimental stimulation of the OH system [11, 13] may be a secondary response to OH-driven energy expenditure [33], rather than a primary function of OH cells.

Our findings identify interesting directions for future work. We found that the weight gain in OH-cell-deficient mice could be prevented by mild caloric restriction. This suggests that development of non-pharmacological interventions may be useful in managing excessive weight gain in neuropsychiatric conditions associated with reduced OH signaling [3, 21, 30, 34]. Furthermore, our results suggest that OH cells—whose hyperactivity has been implicated in pathological states such as panic anxiety [5]—could be inhibited by simple voluntary actions such as eating, irrespective of the nature of the food. Further research into neuroscience-based lifestyle interventions for anxiety and obesity might lead to treatments that are easier to implement and have fewer side effects.

Experimental Procedures

OH cell activity was recorded in vivo using fiber photometry of the GCaMP6s activity indicator targeted to OH cells either using previously characterized orexin-Cre mice and Cre-inducible GCaMP6s viral vectors [35, 36] (Figure 1; Figure S1B) or using a newly generated orexin promoter-dependent adeno-associated virus (AAV)-GCaMP6s vector (characterized in Figures S2C–S2F and described in the Supplemental Experimental Procedures). OH cells were specifically and completely inactivated using a diphtheria toxin receptor-mediated cell-ablation strategy in newly generated OH-DTR transgenic mice described in the Supplemental Experimental Procedures. Food intake was monitored using a TSE PhenoMaster system, whose sensitivity and accuracy were directly determined in our laboratory (Figures S4A–S4D). Immunohistochemistry and glucose tolerance tests were performed using standard techniques (see the Supplemental Experimental Procedures).

Author Contributions

J.A.G. conducted most of the experiments; L.T.J. created and characterized the DTR transgenic mice; P.I. conducted the experiments in Figures S2C–S2F; M.S. contributed to the experiments in Figure S2C; D.B. and L.F. designed the study and obtained funding; and D.B., L.F., and L.T.J. wrote the paper.

Acknowledgments

We thank Drs. Cornelia Schöne, Rui Costa, and Guohong Cui for their assistance with fiber photometry. This work was funded by The Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. L.F. is supported by the MRC and the Wellcome Trust.

Published: August 18, 2016

Footnotes

Supplemental Information includes Supplemental Experimental Procedures, four figures, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.cub.2016.07.013.

Contributor Information

Lars Fugger, Email: lars.fugger@imm.ox.ac.uk.

Denis Burdakov, Email: denis.burdakov@kcl.ac.uk.

Supplemental Information

Document S1. Supplemental Experimental Procedures and Figures S1–S4
mmc1.pdf (1.3MB, pdf)
Movie S1. Real-Time Recording of Orexin/Hypocretin Population Activity, Top Left, during a Continuous Licking Bout in a Freely Moving Mouse, Related to Figure 1

The arrow shows the location of the food spout containing liquid food (strawberry milkshake). The red dot marks the time when the mouse starts licking.

mmc2.jpg (429.7KB, jpg)
Document S2. Article plus Supplemental Information
mmc3.pdf (3.8MB, pdf)

References

  • 1.Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437–451. doi: 10.1016/s0092-8674(00)81973-x. [DOI] [PubMed] [Google Scholar]
  • 2.Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30:345–354. doi: 10.1016/s0896-6273(01)00293-8. [DOI] [PubMed] [Google Scholar]
  • 3.Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469–474. doi: 10.1016/s0896-6273(00)00058-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355:39–40. doi: 10.1016/S0140-6736(99)05582-8. [DOI] [PubMed] [Google Scholar]
  • 5.Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., Träskman-Bendz L., Goddard A.W., Brundin L., Shekhar A. A key role for orexin in panic anxiety. Nat. Med. 2010;16:111–115. doi: 10.1038/nm.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res. 2005;1044:116–121. doi: 10.1016/j.brainres.2005.03.002. [DOI] [PubMed] [Google Scholar]
  • 7.Li Y., Li S., Wei C., Wang H., Sui N., Kirouac G.J. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl.) 2010;212:251–265. doi: 10.1007/s00213-010-1948-y. [DOI] [PubMed] [Google Scholar]
  • 8.Johnson P.L., Molosh A., Fitz S.D., Truitt W.A., Shekhar A. Orexin, stress, and anxiety/panic states. Prog. Brain Res. 2012;198:133–161. doi: 10.1016/B978-0-444-59489-1.00009-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Heydendael W., Sengupta A., Beck S., Bhatnagar S. Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol. Behav. 2014;130:182–190. doi: 10.1016/j.physbeh.2013.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA. 2005;102:19168–19173. doi: 10.1073/pnas.0507480102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–585. doi: 10.1016/s0092-8674(00)80949-6. [DOI] [PubMed] [Google Scholar]
  • 12.Diano S., Horvath B., Urbanski H.F., Sotonyi P., Horvath T.L. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets. Endocrinology. 2003;144:3774–3778. doi: 10.1210/en.2003-0274. [DOI] [PubMed] [Google Scholar]
  • 13.Inutsuka A., Inui A., Tabuchi S., Tsunematsu T., Lazarus M., Yamanaka A. Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons. Neuropharmacology. 2014;85:451–460. doi: 10.1016/j.neuropharm.2014.06.015. [DOI] [PubMed] [Google Scholar]
  • 14.Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron. 2005;46:787–798. doi: 10.1016/j.neuron.2005.04.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Williams R.H., Jensen L.T., Verkhratsky A., Fugger L., Burdakov D. Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl. Acad. Sci. USA. 2007;104:10685–10690. doi: 10.1073/pnas.0702676104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sunanaga J., Deng B.S., Zhang W., Kanmura Y., Kuwaki T. CO2 activates orexin-containing neurons in mice. Respir. Physiol. Neurobiol. 2009;166:184–186. doi: 10.1016/j.resp.2009.03.006. [DOI] [PubMed] [Google Scholar]
  • 17.González J.A., Iordanidou P., Strom M., Adamantidis A., Burdakov D. Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks. Nat. Commun. 2016;7:11395. doi: 10.1038/ncomms11395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA. 1999;96:10911–10916. doi: 10.1073/pnas.96.19.10911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003;38:701–713. doi: 10.1016/s0896-6273(03)00331-3. [DOI] [PubMed] [Google Scholar]
  • 20.Kuwaki T., Zhang W. Orexin neurons and emotional stress. Vitam. Horm. 2012;89:135–158. doi: 10.1016/B978-0-12-394623-2.00008-1. [DOI] [PubMed] [Google Scholar]
  • 21.Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., Okun M., Rogers W., Brooks S., Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 2001;50:381–388. doi: 10.1002/ana.1130. [DOI] [PubMed] [Google Scholar]
  • 22.Tabuchi S., Tsunematsu T., Black S.W., Tominaga M., Maruyama M., Takagi K., Minokoshi Y., Sakurai T., Kilduff T.S., Yamanaka A. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J. Neurosci. 2014;34:6495–6509. doi: 10.1523/JNEUROSCI.0073-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nevsimalova S., Vankova J., Stepanova I., Seemanova E., Mignot E., Nishino S. Hypocretin deficiency in Prader-Willi syndrome. Eur. J. Neurol. 2005;12:70–72. doi: 10.1111/j.1468-1331.2004.00969.x. [DOI] [PubMed] [Google Scholar]
  • 24.Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci. 2005;25:2429–2433. doi: 10.1523/JNEUROSCI.4925-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cui G., Jun S.B., Jin X., Pham M.D., Vogel S.S., Lovinger D.M., Costa R.M. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature. 2013;494:238–242. doi: 10.1038/nature11846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gunaydin L.A., Grosenick L., Finkelstein J.C., Kauvar I.V., Fenno L.E., Adhikari A., Lammel S., Mirzabekov J.J., Airan R.D., Zalocusky K.A. Natural neural projection dynamics underlying social behavior. Cell. 2014;157:1535–1551. doi: 10.1016/j.cell.2014.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Saito M., Iwawaki T., Taya C., Yonekawa H., Noda M., Inui Y., Mekada E., Kimata Y., Tsuru A., Kohno K. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 2001;19:746–750. doi: 10.1038/90795. [DOI] [PubMed] [Google Scholar]
  • 28.Luquet S., Perez F.A., Hnasko T.S., Palmiter R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310:683–685. doi: 10.1126/science.1115524. [DOI] [PubMed] [Google Scholar]
  • 29.Beitinger P.A., Fulda S., Dalal M.A., Wehrle R., Keckeis M., Wetter T.C., Han F., Pollmächer T., Schuld A. Glucose tolerance in patients with narcolepsy. Sleep. 2012;35:231–236. doi: 10.5665/sleep.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fortuyn H.A., Swinkels S., Buitelaar J., Renier W.O., Furer J.W., Rijnders C.A., Hodiamont P.P., Overeem S. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep. 2008;31:335–341. doi: 10.1093/sleep/31.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ellacott K.L., Morton G.J., Woods S.C., Tso P., Schwartz M.W. Assessment of feeding behavior in laboratory mice. Cell Metab. 2010;12:10–17. doi: 10.1016/j.cmet.2010.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang S., Zeitzer J.M., Sakurai T., Nishino S., Mignot E. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J. Physiol. 2007;581:649–663. doi: 10.1113/jphysiol.2007.129510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Teske J.A., Mavanji V. Energy expenditure: role of orexin. Vitam. Horm. 2012;89:91–109. doi: 10.1016/B978-0-12-394623-2.00006-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Brundin L., Björkqvist M., Petersén A., Träskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 2007;17:573–579. doi: 10.1016/j.euroneuro.2007.01.005. [DOI] [PubMed] [Google Scholar]
  • 35.Matsuki T., Nomiyama M., Takahira H., Hirashima N., Kunita S., Takahashi S., Yagami K., Kilduff T.S., Bettler B., Yanagisawa M., Sakurai T. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc. Natl. Acad. Sci. USA. 2009;106:4459–4464. doi: 10.1073/pnas.0811126106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Schöne C., Cao Z.F., Apergis-Schoute J., Adamantidis A., Sakurai T., Burdakov D. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 2012;32:12437–12443. doi: 10.1523/JNEUROSCI.0706-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Supplemental Experimental Procedures and Figures S1–S4
mmc1.pdf (1.3MB, pdf)
Movie S1. Real-Time Recording of Orexin/Hypocretin Population Activity, Top Left, during a Continuous Licking Bout in a Freely Moving Mouse, Related to Figure 1

The arrow shows the location of the food spout containing liquid food (strawberry milkshake). The red dot marks the time when the mouse starts licking.

mmc2.jpg (429.7KB, jpg)
Document S2. Article plus Supplemental Information
mmc3.pdf (3.8MB, pdf)

RESOURCES